THE EFFECTS OF FREE-RADICAL SCAVENGERS ON THE OXIDATION OF LOW-DENSITY LIPOPROTEINS BY MACROPHAGES

被引:12
|
作者
WILKINS, GM
LEAKE, DS
机构
[1] Department of Biochemistry and Physiology, School of Animal and Microbial Sciences, University of Reading, Reading, Berkshire RG6 2AJ
来源
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM | 1994年 / 1215卷 / 03期
基金
英国惠康基金;
关键词
LDL; OXIDATION; MACROPHAGE; SUPEROXIDE DISMUTASE; OXYGEN RADICAL; ATHEROSCLEROSIS;
D O I
10.1016/0005-2760(94)90050-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oxidised LDL has been implicated in the pathogenesis of atherosclerosis. Macrophages can oxidatively modify low-density lipoprotein (LDL) in vitro. The mechanisms of this oxidation process are presently unclear. In this study, we have investigated the effects of compounds and enzymes widely used to quench or scavenge active oxygen species to try to identify the oxidative species involved in this process. The data obtained suggest that hydrogen peroxide may possibly play a role in LDL oxidation by macrophages, whereas singlet oxygen and hydroxyl radicals may not. The role of superoxide anions was uncertain because copper-zinc superoxide dismutase (Cu/Zn-SOD) and manganese SOD (Mn-SOD), widely used to determine superoxide-dependency in other systems may be unsuitable in this particular system. Cu/Zn-SOD at high concentrations displayed a variability in its effects, sometimes augmenting LDL oxidation and sometimes inhibiting it. In the experiments in which Cu/Zn-SOD augmented LDL oxidation, heat inactivation of the enzyme decreased the augmentation; in the experiments in which Cu/Zn-SOD inhibited LDL oxidation, it retained its inhibitory effect after heat inactivation. Mn-SOD always inhibited modification even after heat inactivation. We have therefore concluded that superoxide involvement in LDL oxidation by macrophages is still uncertain and the uncertainty will remain until a suitable probe is found.
引用
收藏
页码:250 / 258
页数:9
相关论文
共 50 条
  • [1] THE EFFECT OF INHIBITORS OF FREE-RADICAL GENERATING ENZYMES ON LOW-DENSITY-LIPOPROTEIN OXIDATION BY MACROPHAGES
    WILKINS, GM
    LEAKE, DS
    BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1994, 1211 (01): : 69 - 78
  • [2] Oxidation of low-density lipoproteins and atherogenesis
    Dejager, S
    Chapman, J
    OCL-OLEAGINEUX CORPS GRAS LIPIDES, 1996, 3 (03): : 195 - 199
  • [3] Sequestration of aggregated low-density lipoproteins by macrophages
    Kruth, HS
    CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (05) : 483 - 488
  • [4] SIMVASTATIN INHIBITS THE OXIDATION OF LOW-DENSITY LIPOPROTEINS BY ACTIVATED HUMAN MONOCYTE-DERIVED MACROPHAGES
    GIROUX, LM
    DAVIGNON, J
    NARUSZEWICZ, M
    BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1165 (03) : 335 - 338
  • [5] A PROTECTIVE ROLE FOR NITRIC-OXIDE IN THE OXIDATIVE MODIFICATION OF LOW-DENSITY LIPOPROTEINS BY MOUSE MACROPHAGES
    YATES, MT
    LAMBERT, LE
    WHITTEN, JP
    MCDONALD, I
    MANO, M
    KU, G
    MAO, SJT
    FEBS LETTERS, 1992, 309 (02) : 135 - 138
  • [6] CONTRIBUTION OF VITAMIN-A TO THE OXIDATION RESISTANCE OF HUMAN LOW-DENSITY LIPOPROTEINS
    LIVREA, MA
    TESORIERE, L
    BONGIORNO, A
    PINTAUDI, AM
    CIACCIO, M
    RICCIO, A
    FREE RADICAL BIOLOGY AND MEDICINE, 1995, 18 (03) : 401 - 409
  • [7] MACROPHAGE PROTEASES CAN MODIFY LOW-DENSITY LIPOPROTEINS TO INCREASE THEIR UPTAKE BY MACROPHAGES
    LEAKE, DS
    RANKIN, SM
    COLLARD, J
    FEBS LETTERS, 1990, 269 (01) : 209 - 212
  • [8] A kinetic study of the oxidation effects of amphotericin B on human low-density lipoproteins
    Barwicz, J
    Gruda, I
    Tancrède, P
    FEBS LETTERS, 2000, 465 (01) : 83 - 86
  • [9] Plasma lipid oxidation and susceptibility of low-density lipoproteins to oxidation in male patients with stable coronary artery disease
    Karmansky, I
    Shnaider, H
    Palant, A
    Gruener, N
    CLINICAL BIOCHEMISTRY, 1996, 29 (06) : 573 - 579
  • [10] Effects of lycopene on the susceptibility of low-density lipoproteins to oxidative modification
    Safari, Mohammad Reza
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2007, 6 (03): : 173 - 177